Tudorza Pressair Approved for COPD

07/24/2012 majac Your Health Matters

TUESDAY, July 24 (HealthDay News) — The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older.

Share on Facebook

Save

COPD, Drug Administration